Brind.

Baird reduced its price target for Elevance Health, Inc. on August 8, 2025.

1 report, 1 independent Updated Aug 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Baird Elevance Health, Inc.

Keep exploring

The entities involved

Baird
financial services provider

Nothing else this week.
Elevance Health, Inc.
American healthcare company

Nothing else this week.

Related events

Morgan Stanley and Raymond James Financial raised their price objectives for Elevance Health, Inc. on September 15, 2026.Sep 15
TD Cowen boosted its price objective on Elevance Health, while the National Pension Service reduced its holdings and filed 13F with the SEC.Sep 11

Coverage

Newest first; wire copies grouped

Aug 8Insider MonkeyBaird Reduces PT on Elevance Health (ELV) Stock, Maintains Neutral Elevance Health, Inc. (NYSE:ELV) is one of the Most Undervalued Long Term Stocks to Buy According to Hedge Funds. On July 25, Baird